Published • loading... • Updated
Executive Change: Uniquity Bio Appoints Matthew Hartzell as Chief Financial Officer
Summary by Intelligence360 News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Executive Change: Uniquity Bio Appoints Matthew Hartzell as Chief Financial Officer
Jupiter, FL – Uniquity Bio has announced the appointment of Matthew Hartzell as Chief Financial Officer. About Uniquity Bio: Uniquity Bio is a clinical-stage biopharmaceutical company focused on developing innovative medicines for immune-mediated diseases, with a particular emphasis on immunology and inflammation. Built by a leadership team with decades of experience in global pharma, biotech, and research, the company combines scientific rigor …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
